NVDA
NVIDIA
-- 130.150 TSLA
Tesla
-- 442.480 QUBT
Quantum Computing
-- 25.870 MU
Micron Technology
-- 104.490 RGTI
Rigetti Computing
-- 10.7019 
Reverse Stock Split Rule
$Tonix Pharmaceuticals (TNXP.US)$ TNXP cannot do as RS until May 25 due to the new SEC rules. The sp must be over 1 by feb 5th so if it not over 1 by then thry will have to file a 180 extension so that new date will be Aug 2025 for 1. look it up yourself, there is absolutely ZERO chance an RS will occur before May next year
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
74537207 : however, they can dilute it further by offering, which all also screw the shareholders
72645641 : Thank you for sharing, we all need these informations to increase some confidence at the moment
Kyrios 74537207 : anyhow we are fucked
72645641 : But if they can’t RS, is there a chance their stock price is too low to be unlisted by NASDAQ?
74537207 Kyrios : speak for yourself, I sold at 1.53 and then re-entered at 0.36 during postmarket yesterday
72119175 : We need $ 1.00 ASAP
ambitious Unicorn_63 OP : Why do you think pharmaceutical companies tend to dilute a lot until they are revenue positive? Here’s what usually happens….either buyout or partnership. Not saying it will happen here but that is the trend
ambitious Unicorn_63 OP 72645641 : No man, 180 extensions always get approved it’s just paperwork
ambitious Unicorn_63 OP 72645641 : I’m not pumping, just telling it like it is unlike some here with all the FUD
74537207 ambitious Unicorn_63 OP : exactly, first comes a pump, then a bigger dump and then some offering to add insult to injury
View more comments...